Ellergezen, P. Et Al. 2023. Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome. Archives of Rheumatology , vol.38, no.2 , 307-314.

Ellergezen, P., ALP, A., ÇAVUN, S., ÇELEBİ, M., & Macunluoğlu, A. C., (2023). Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome. Archives of Rheumatology , vol.38, no.2, 307-314.

Ellergezen, Pınar Et Al. "Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome," Archives of Rheumatology , vol.38, no.2, 307-314, 2023

Ellergezen, Pınar Et Al. "Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome." Archives of Rheumatology , vol.38, no.2, pp.307-314, 2023

Ellergezen, P. Et Al. (2023) . "Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome." Archives of Rheumatology , vol.38, no.2, pp.307-314.

@article{article, author={Pınar Ellergezen Et Al. }, title={Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome}, journal={Archives of Rheumatology}, year=2023, pages={307-314} }